Øivind Enger

Øivind Enger was elected to the board of OculAudio in 2022 in connection with Sarsia Seed Fond II’s investment in the company.

Øivind Enger has a Ph.D. in microbiology from the University of Bergen, where he also worked as a researcher for a number of years. He has more than 40 published peer-reviewed works in international scientific journals. Øivind worked for several years with technology transfer between Norwegian universities and business before in 2006, as a partner in Sarsia Management, he was involved in the establishment of the investment fund Sarsia Seed. Sarsia Management currently manages three investment funds that invest in early-stage companies. Øivind is a board member of several medical technology companies and pharmaceutical companies.



Phone: +47 900 62 303
E-mail: oivind.enger@sarsiaseed.com